Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 11 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT04220450
- Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)WithdrawnNCT04216693Phase 2
- NAFLD in HIV-infected PatientsStatus unknownNCT04215926
- A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease PatientsCompletedNCT04197479Phase 3
- The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult SubjectsCompletedNCT04194242Phase 1
- An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)Status unknownNCT04193982Phase 3
- Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)Status unknownNCT04191044
- Sleep Apnoea Syndrome and Hepatocellular CarcinomaWithdrawnNCT04190498
- Study of NGM395 in Adult ParticipantsCompletedNCT04187339Phase 1
- Comparison of Dietary Sugar Reduction MethodsCompletedNCT04186793Not applicable
- A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American MenCompletedNCT04186260Not applicable
- Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver DiseaseCompletedNCT04182646Not applicable
- A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHCompletedNCT04173065Phase 2
- Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORERCompletedNCT04165343
- Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT04161703Not applicable
- Safety and Tolerability of Oral Proglumide for NASHCompletedNCT04152473Phase 1
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy SubjectsCompletedNCT04146805Phase 1
- Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)CompletedNCT04146636Not applicable
- Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedNCT04142749Phase 3
- A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese SubjectsCompletedNCT04142424Phase 1
- Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT04140123Phase 1/2
- Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 PharmacokineticsCompletedNCT04137055Phase 1
- Patient and Physician Perspectives on Non-Alcoholic Fatty Liver DiseaseActive, not recruitingNCT04132440
- Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in HumansCompletedNCT04130321Not applicable
- The Role of Bariatric Surgeries in Management of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT04127370Not applicable
- Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic SyndromeCompletedNCT04117802Not applicable
- Longitudinal Assessment of Multiple Organs in Patients With Type 2 DiabetesActive, not recruitingNCT04114682
- Curcumin for Pediatric Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04109742Phase 2
- NAFLD Study: US vs Liver BiopsyStatus unknownNCT04101162Not applicable
- Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.Status unknownNCT04099147
- Biological Adaptations of Strength Training.CompletedNCT04098484Not applicable
- HOMA-IR as a Screening Test in NAFLDCompletedNCT04084925
- Prevalence of NAFLD and Correlation With Its Main Risk Factors Among EgyptianStatus unknownNCT04081571
- The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic SteatohepatitisCompletedNCT04080947Phase 1/2
- The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty LiverStatus unknownNCT04074889Not applicable
- Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and StoolCompletedNCT04067440
- Role of a Wheat Containing Diet on Non-alcoholic SteatohepatitisCompletedNCT04066400Not applicable
- Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASHStatus unknownNCT04060368Not applicable
- Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease.CompletedNCT04059068
- Nonalcoholic Fatty Liver Disease in Morbidly Obese PatientsStatus unknownNCT04059029
- Glycemic Index/Saturated Fatty Acid Diet and Hepatic FatCompletedNCT04054297Not applicable
- Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT04049396Not applicable
- Bariatric Surgery on NASHCompletedNCT04043585
- Glucagon Resistance in Patients With NAFLDCompletedNCT04042142Not applicable
- Vitamin D in Fatty Liver DiseaseCompletedNCT04038853Phase 4
- Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound StudyStatus unknownNCT04012242
- Diabetes, Exercise and Liver Fat (DELIVER)CompletedNCT04004273Not applicable
- A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver DiseaseCompletedNCT03998514Phase 1
- Hepatic Energy Fluxes in NASH and NAS PatientsActive, not recruitingNCT03997422Not applicable
- Exercise Study in Subjects With NAFLDCompletedNCT03995056Not applicable
- Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin ECompletedNCT03988725Not applicable
- Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver DiseaseCompletedNCT03986684
- Super HEROES: Searching How the Extract Rebaudioside Occludes Excess SteatosisCompletedNCT03985020Not applicable
- Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light SpectroscopyCompletedNCT03978247Not applicable
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis PatientsCompletedNCT03976687Phase 1
- Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese AdultsStatus unknownNCT03972631Not applicable
- A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASHStatus unknownNCT03970031Phase 3
- NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)Status unknownNCT03968354
- Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH PatientsCompletedNCT03963921Phase 1/2
- Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic SteatohepatitisWithdrawnNCT03962608Not applicable
- Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)TerminatedNCT03953456Phase 2
- A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLDCompletedNCT03950882Phase 1
- To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 DiabetesStatus unknownNCT03950505Phase 4
- Chia Supplementation and Non Alcoholic Fatty Liver DiseaseCompletedNCT03942822Not applicable
- Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT03936803Not applicable
- Integrated Approaches for Identifying Molecular Targets in Liver DiseaseCompletedNCT03915002
- 12-Month Once-a-week HIIT Improves Body Adiposity and Liver FatCompletedNCT03912272Not applicable
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesCompletedNCT03910361Phase 4
- A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and FibrosisActive, not recruitingNCT03900429Phase 3
- Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health"CompletedNCT03897218Not applicable
- An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLDTerminatedNCT03868566Phase 2
- NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney TransplantationTerminatedNCT03866421
- NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction ReversalWithdrawnNCT03864835Not applicable
- The Effect of Curcumin on Liver Fat Content in Obese SubjectsCompletedNCT03864783Not applicable
- Hepatic Histology and Metabolism Following Total Pancreatectomy and PancreaticoduodenectomyStatus unknownNCT03864744
- NAFLD in Diabetes Type 2 in Primary CareCompletedNCT03864510
- Feasibility of VIIT in Adults With NASHCompletedNCT03861819Not applicable
- The Liver in the World Trade Center Health Program General Responder Cohort and ControlsCompletedNCT03858920
- Nicotinamide in Non-Alcoholic Fatty Liver Disease PatientsCompletedNCT03850886Phase 2
- Effectiveness and Tolerability of Phentermine in Patients Under Bariatric SurgeryCompletedNCT03849729Phase 4
- Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).Status unknownNCT03848390Not applicable
- Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver DiseaseCompletedNCT03847116
- Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisStatus unknownNCT03842748
- Role of Obeticholic Acid in the Patients of NAFLD With Raised ALTCompletedNCT03836937Not applicable
- Postprandial Lipotoxicity and Nonalcoholic Fatty Liver DiseaseCompletedNCT03836443Not applicable
- NAFLD Among Patients With Type 2 Diabetes and CKDCompletedNCT03826381
- NASH and Coronary DiseaseStatus unknownNCT03819283Not applicable
- Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic SteatohepatitisStatus unknownNCT03803540Phase 1
- Hepaxa Management of Non-alcoholic Fatty Liver DiseaseStatus unknownNCT03801577Not applicable
- Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver DiseaseCompletedNCT03796975Phase 4
- Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver DiseaseCompletedNCT03791203Not applicable
- Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or ObesityStatus unknownNCT03787108
- Time Restricted Feeding on Nonalcoholic Fatty Liver DiseaseCompletedNCT03786523Not applicable
- Ketogenic Diet in Non-alcoholic Fatty Liver DiseaseCompletedNCT03784716Not applicable
- A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female SubjectsCompletedNCT03783897Phase 1
- Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled TrialCompletedNCT03774511Not applicable
- Immunomediated Non-alcoholic SteaTohepatitis; Prevalence and Characterization. INSTInCT StudyStatus unknownNCT03760172
- Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) CirrhoticsCompletedNCT03753438
- Mechanism of DCs Dysfunction in Chronic HBV InfectionStatus unknownNCT03753308
- Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER TrialStatus unknownNCT03749070Not applicable